Literature DB >> 1728946

Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature.

J A Bridge1, J R Neff, B J Mouron.   

Abstract

Giant cell tumor of bone (GCT) is a distinct clinical, radiographic, and pathologic benign entity that constitutes 5% of all primary bone tumors. For a 5-year period, 47 benign GCTs and 1 malignant GCT from 34 different patients were cytogenetically characterized. Analysis showed clonal karyotypic abnormalities in 16 specimens. Clonal structural abnormalities detected in more than one patient included translocations involving 11p15, fus(14p;21p), and fus(15p;21p). None of the clonal numerical abnormalities observed occurred in more than one patient. Thirty-seven of the 44 successfully analyzed specimens (84%) demonstrated telomeric fusion, with most frequent involvement of chromosomal telomeres 11p, 13p, 15p, 18p, 19p, and 21p. We also compared the presence or absence of random and/or clonal karyotypic abnormalities with clinical behavior to determine if a relationship existed. Most notably, chromosomal abnormalities were detected in all 13 successfully analyzed recurrent lesions, five of which were clonally aberrant. This study summarizes the cytogenetic findings and their relevance in 48 specimens analyzed at our institution and reviews the findings of the 18 other published cases.

Entities:  

Mesh:

Year:  1992        PMID: 1728946     DOI: 10.1016/0165-4608(92)90125-r

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  22 in total

1.  Giant cell tumor of soft tissue is genetically distinct from its bone counterpart.

Authors:  Jen-Chieh Lee; Cher-Wei Liang; Christopher Dm Fletcher
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 7.842

Review 2.  Giant cell tumour of bone: morphological, biological and histogenetical aspects.

Authors:  Mathias Werner
Journal:  Int Orthop       Date:  2006-09-30       Impact factor: 3.075

3.  Robertsonian translocations in Paget's disease of bone.

Authors:  H S Schwartz; M G Butler
Journal:  J Orthop Res       Date:  1997-09       Impact factor: 3.494

4.  T2*-weighted MR imaging findings of giant cell tumors of bone: radiological-pathological correlation.

Authors:  Hironori Nishibori; Hiroki Kato; Masaya Kawaguchi; Akihito Nagano; Masayuki Matsuo
Journal:  Jpn J Radiol       Date:  2019-03-11       Impact factor: 2.374

5.  Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis.

Authors:  Joslin M Bowen; Justin M Cates; Shera Kash; Doha Itani; Adriana Gonzalez; Dali Huang; Andre Oliveira; Julia A Bridge
Journal:  Cancer Genet       Date:  2012-05

Review 6.  Giant Cell Tumor of Bone - An Overview.

Authors:  Anshul Sobti; Pranshu Agrawal; Sanjay Agarwala; Manish Agarwal
Journal:  Arch Bone Jt Surg       Date:  2016-01

7.  USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts.

Authors:  Andre M Oliveira; Antonio R Perez-Atayde; Carrie Y Inwards; Fabiola Medeiros; Victoria Derr; Bae-Li Hsi; Mark C Gebhardt; Andrew E Rosenberg; Jonathan A Fletcher
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

8.  Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.

Authors:  Teresa Morgan; Gerald J Atkins; Melanie K Trivett; Sandra A Johnson; Maya Kansara; Stephen L Schlicht; John L Slavin; Paul Simmons; Ian Dickinson; Gerald Powell; Peter F M Choong; Andrew J Holloway; David M Thomas
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

9.  Telomere reduction in giant cell tumor of bone and with aging.

Authors:  H S Schwartz; G A Dahir; M G Butler
Journal:  Cancer Genet Cytogenet       Date:  1993-12

10.  Metastatic potential of an aneurysmal bone cyst.

Authors:  Addy C M van de Luijtgaarden; Rene P H Veth; Piet J Slootweg; Pauline M Wijers-Koster; Leo J Schultze Kool; Judith V M G Bovee; Winette T A van der Graaf
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.